Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Gynecologic 1Genitourinary 1Breast 1

Conditions

Breast Neoplasms 15Sarcoma 2Neoplasm Metastasis 2Carcinoma, Non-Small-Cell Lung 2Stomach Neoplasms 1Small Cell Lung Carcinoma 1Prostatic Neoplasms 1Ovarian Neoplasms 1Motor Activity 1Lung Neoplasms 1HER2-positive Breast Cancer 1HER2 Positive Breast Cancer 1Colorectal Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms, Male 1Breast Diseases 1Breast Cancer Female 1Brain Neoplasms 1Adenocarcinoma 1

Interventions

X-Rays 4anlotinib 3Standard of Care 3Radiosurgery 3Psychiatric Rehabilitation 3Early Intervention, Educational 3Drug Therapy 3Counseling 3pegylated granulocyte colony-stimulating factor 2Therapeutics 2Nicotine 2Exercise 2Cisplatin 2Carboplatin 2Bronchoalveolar Lavage 2Blood Specimen Collection 2toripalimab 1irinotecan sucrosofate 1iodixanol 1durvalumab 1chiauranib 1apatinib 1Varenicline 1Triage 1Trastuzumab 1Tomography, X-Ray Computed 1Tobacco Use Cessation Devices 1Taxes 1Surveys and Questionnaires 1Radiotherapy, Conformal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Small Cell Lung Carcinoma × Trastuzumab × Clear all
NCT00433407 2012-10-04

T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors

Jonsson Comprehensive Cancer Center

Phase NA Completed
12 enrolled
BreastGenitourinaryGynecologicSarcomaThoracic

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Breast Neoplasms, Male, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡